Relationship of vitamin D, HIV, HIV treatment, and lipid levels in the women's interagency HIV study of HIV-infected and uninfected women in the United States

Journal of the International Association of Providers of AIDS Care

Volumn 13, Issue 3, 2014, Pages 250-259

  Schwartz, Janice B ^a,b   Moore, Kelly L ^a   Yin, Michael ^c   Sharma, Anjali ^d   Merenstein, Dan ^e   Islam, Talat ^f   Golub, Elizabeth T ^g   Tien, Phyllis C ^b   Adeyemi, Oluwatoyin M ^h,i  

^a Research Department Jewish Home   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c NewYork Presbyterian Hospital   (United States)

^d SUNY Downstate Medical Center   (United States)

^e GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

^f UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^g JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^h Jr Hospital of Cook County   (United States)

ⁱ RUSH UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

25 OH vitamin D; cholesterol; HIV infected; HIV uninfected; LDL cholesterol; lipids; triglycerides; vitamin D; WIHS

Indexed keywords

25 HYDROXYVITAMIN D; CHOLESTEROL; EFAVIRENZ; HIGH DENSITY LIPOPROTEIN; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; VITAMIN D;

ADULT; ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MIDDLE AGED; PRIORITY JOURNAL; UNITED STATES; VITAMIN D DEFICIENCY;

25-OH VITAMIN D; CHOLESTEROL; HIV INFECTED; HIV UNINFECTED; LDL CHOLESTEROL; LIPIDS; TRIGLYCERIDES; VITAMIN D; WIHS;

ADULT; ANTI-RETROVIRAL AGENTS; FEMALE; HIV INFECTIONS; HUMANS; LIPIDS; MIDDLE AGED; MULTIVARIATE ANALYSIS; UNITED STATES; VITAMIN D; VITAMIN D DEFICIENCY;

EID: 84900338845     PISSN: 23259574     EISSN: 23259582     Source Type: Journal    
DOI: 10.1177/2325957413506748     Document Type: Article

References (53)

1. Holick M., Vitamin D. The underappreciated D-lightful hormone that is important for skeletal and cellular health. Curr Opin Endocrinol Diabetes. 2002 ; 9: 87-98
2. Nagpal S, Na S, Rathnachalam R. Noncalcemic actions of vitamin D receptor ligands. Endocr Rev. 2005 ; 26 (5). 662-687
3. Lips P. Vitamin D physiology. Prog Biophys Molec Biol. 2006 ; 92 (1). 4-8
4. Norman A. Vitamin D receptor (VDR): new assignments for an already busy receptor. Endocrinology. 2006 ; 147 (12). 5542-5548
5. Ma Y, Khalifa B, Yee YK, et al. Identification and characterization of noncalcemic, tissue-selective, nonsecosteroidal vitamin D receptor modulators. J Clin Invest. 2006 ; 116 (4). 892-904
6. Holick M. Optimal vitamin D status for the prevention and treatment of osteoporosis. Drugs Aging. 2007 ; 24 (12). 1017-1029
7. Holick M, Chen T. Vitamin D deficiency: a worldwide problem with health consequences. Am J Clin Nutr. 2008 ; 87 (4). 1080S - 1086S
8. Maalouf N. The noncalciotropic actions of vitamin D: recent clinical developments. Hypertension. 2008 ; 17 (4). 408-415
9. Michos E, Melamed M. Vitamin D and cardiovascular disease risk. Curr Opin Clin Nutr Metab Care. 2008 ; 11 (1). 7-12
10. Holick M. High prevalence of Vitamin D inadequacy and implications for health. Mayo Clin Proc. 2006 ; 81 (3). 353-373
11. Linnebur SA, Vondracek SF, Vande Griend JP, Ruscin JM, McDermott MT. Prevalence of vitamin D insufficiency in elderly ambulatory outpatients in Denver, Colorado. Am J Geriatr Pharmacother. 2007 ; 5 (1). 1-8
12. Lips P. Vitamin D deficiency and secondary hyperparathyroidism in the elderly: consequences for bone loss and fractures and therapeutic implications. Endocr Rev. 2001 ; 22 (4). 477-501
13. Webb AR, Kline L, Holick MF. Influence of season and latitude on the cutaneous synthesis of vitamin D3: exposure to winter sunlight in Boston and Edmonton will not promote vitamin D3 synthesis in human skin. J Clin Endocrinol Metab. 1988 ; 67 (2). 373-378
14. Martins D, Wolf M, Pan D. Prevalence of cardiovascular risk factors and the serum levels of 25-hydroxyvitamin D in the United States. data from the third national health and nutrition examination survey. Arch Intern Med. 2007 ; 167 (11). 1159-1165
15. Holick M. Vitamin D deficiency. N Engl J Med. 2007 ; 357 (3). 266-281
16. Stephensen CB, Marquis GS, Kruzich LA, Douglas SD, Aldrovandi GM, Wilson CM. Vitamin D status in adolescents and young adults with HIV infection. Am J Clin Nutr. 2006 ; 83 (5). 1135-1141
17. Rodríguez M, Daniels B, Gunawardene S, Robbins GK. High frequency of vitamin D deficiency in ambulatory HIV-positive patients. AIDS Res Hum Retroviruses. 2009 ; 25 (1). 9-14
18. Conrado T, Miranda-Filho Dde B, Ximenes RA, et al. Vitamin D deficiency in HIV-infected women on antiretroviral therapy living in the tropics. J Int Assoc Physicians AIDS Care. 2011 ; 10 (4). 239-245
19. Chiu KC, Chu A, Go VL, Saad MF. Hypovitaminosis D is associated with insulin resistance and beta cell dysfunction. Am J Clin Nutr. 2004 ; 79 (5). 820-825
20. Mak R.. 1,25-dihydroxyvitamin D3 corrects insulin and lipid abnormalities in uremia. Kidney Int. 1998 ; 53 (5). 1353-1357
21. Yeksan M, Türk S, Polat M, Cili A, Erdoan Y. Effects of 1,25(OH)2D3 treatment on lipid levels in uremic hemodialysis patients. Int J Artif Organs. 1992 ; 15 (12). 704-707
22. von Hurst PR, Stonehouse W, Coad J. Vitamin D supplementation reduces insulin resistance in South Asian women living in New Zealand who are insulin resistant and vitamin D deficient - a randomised, placebo-controlled trial. Br J Nutr. 2010 ; 103 (4). 549-555
23. Carbone LD, Rosenberg EW, Tolley EA. 25-Hydroxyvitamin D, cholesterol, and ultraviolet irradiation. Metabolism. 2008 ; 57 (6). 741-748
24. Schwartz J. Effects of vitamin D supplementation in atorvastatin treated patients: a new drug interaction with an unexpected consequence. Clin Pharmacol Ther. 2009 ; 85 (2). 198-203
25. Bacon MC, von Wyl V, Alden C, et al. The Women's Interagency HIV Study: an observational cohort brings clinical science to the bench. Clin Diag Lab Immunol. 2005 ; 12 (9). 1013-1019
26. Barkan SE, Melnick SL, Preston-Martin S, et al. The women's interagency HIV study. WIHS collaborative study group. Epidemiology. 1998 ; 9 (2). 117-125
27. Pérez-Castrillón JL, Vega G, Abad L, et al. Effects of atorvastatin on vitamin D levels in patients with acute ischemic heart disease. Am J Cardiol. 2007 ; 99 (7). 903-905
28. Wilczek H, Sobra J, Justová V. latropathogenic effect of mevacor on vitamin D metabolism. Cas Lek Cesk. 1989 ; 128 (40). 1254-1256
29. Yavuz B, Ertugrul DT, Cil H, et al. Increased levels of 25 hydroxyvitamin D and 1,25-dihydroxyvitamin D after rosuvastatin treatment: a novel pleiotropic effect of statins?. Cardiovasc Drugs Ther. 2009 ; 23 (4). 295-299
30. Wilczek H, Sobra J, Ceska R, et al. Monitoring plasma levels of vitamin D metabolites in simvastatin therapy in patients with familial hypercholesterolemia. Cas Lek Cesk. 1994 ; 133 (23). 727-729
31. Efron B An Introduction to the Bootstrap. New York, NY: Chapman and Hall ; 1993 1993 :
32. Robins J, Rotnitzky A. Semiparametric efficiency in multivariate regression models with missing data. J Am Stat Assoc. 1995 ; 90 (429). 122-129
33. Fox J, Peters B, Prakash M, Arribas J, Hill A, Moecklinghoff C. Improvement in vitamin D deficiency following antiretroviral regime change: results from the MONET trial. AIDS Res Hum Retroviruses. 2011 ; 27 (1). 29-34
34. Holick M. Vitamin D: the other steroid hormone for muscle function and strength. Menopause. 2009 ; 16 (6). 1077-1078
35. Triant VA, Brown TT, Lee H, Grinspoon SK. Fracture prevalence among human immunodeficiency virus (HIV)-infected versus non-HIV-infected patients in a large U.S. healthcare system. J Clin Endocrinol Metab. 2008 ; 93 (9). 3499-3504
36. Deeks S. Immune dysfunction, inflammation, and accelerated aging in patients on antiretroviral therapy. Top HIV Med. 2009 ; 17 (4). 118-123
37. Deeks S, Phillips A. HIV infection, antiretroviral treatment, ageing, and non-AIDS related morbidity. BMJ. 2009 ; 338: 288-292
38. McComsey GA, Tebas P, Shane E, et al. Bone disease in HIV infection: a practical review and recommendations for HIV care providers. Clin Infect Dis. 2010 ; 51 (8). 937-946
39. Deeks S. HIV infection, inflammation, immunosenescence, and aging. Annu Rev Med. 2011 ; 62: 141-155
40. Adeyemi OM, Agniel D, French AL. Vitamin D deficiency in HIV-infected and un-infected women in the US.. 2011 ; 57 (3). 197-204
41. Giovannucci E, Liu Y, Hollis BW. Rimm EB. 25-hydroxyvitamin D and risk of myocardial infarction in men. a prospective study. Arch Intern Med. 2008 ; 168 (11). 1174-1180
42. Dobnig H, Pilz S, Scharnagl H, et al. Independent association of low serum 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D levels with all-cause and cardiovascular mortality. Arch Intern Med. 2008 ; 168 (12). 1340-1349
43. Wang TJ, Pencina MJ, Booth SL, et al. Vitamin D deficiency and risk of cardiovascular disease. Circulation. 2008 ; 117 (4). 503-511
44. Watson KE, Abrolat ML, Malone LL, et al. Active serum vitamin D levels are inversely correlated with coronary calcification. Circulation. 1997 ; 96 (6). 1775-1760
45. Melamed ML, Muntner P, Michos ED, et al. Serum 25-Hydroxyvitamin D levels and the prevalence of peripheral arterial disease. results from NHANES 2001-2004. Arterioscler Thromb Vasc Biol. 2008 ; 28 (6). 1179-1185
46. Poole KE, Loveridge N, Barker PJ, et al. Reduced vitamin D in acute stroke. Stroke. 2006 ; 37 (1). 243-245
47. Hsue PY, Giri K, Erickson S, et al. Clinical features of acute coronary syndromes in patients with human immunodeficiency virus infection. Circulation. 2004 ; 109 (3). 316-319
48. Hsue PY, Lo JC, Franklin A, et al. Progression of atherosclerosis as assessed by carotid intima-media thickness in patients with HIV infection. Circulation. 2004 ; 109 (13). 1603-1608
49. Grunfeld C. Dyslipidemia and its treatment in HIV Infection. Top HIV Med. 2010 ; 18 (3). 112-118
50. Carlson LA, Derblom H, Lanner A. Effect of different doses of vitamin D on serum cholesterol and triglyceride levels in health men. Atherosclerosis. 1970 ; 12 (2). 313-317
51. Gannagé-Yared MH, Azoury M, Mansour I, Baddoura R, Halaby G, Naaman R. Effects of a short-term calcium and vitamin D treatment on serum cytokines, bone markers, insulin and lipid concentrations in healthy post-menopausal women. J Endocrinol Invest. 2003 ; 26 (8). 748-753
52. Heikkinen AM, Tuppurainen MT, Niskanen L, Komulainen M, Penttilä I, Saarikoski S. Long-term vitamin D3 supplementation may have adverse effets on serum lipids during postmenopausal hormone replacement thereapy. Eur J Endocrinolog. 1997 ; 137 (5). 495-502
53. Aberg J. Cardiovascular complications in HIV management: past, present, and future. J Acquir Immune Defic Syndr. 2009 ; 50 (1). 54-64